KR20070095494A - Semi-solid gel composition for adipose tissue regeneration - Google Patents

Semi-solid gel composition for adipose tissue regeneration Download PDF

Info

Publication number
KR20070095494A
KR20070095494A KR1020050090202A KR20050090202A KR20070095494A KR 20070095494 A KR20070095494 A KR 20070095494A KR 1020050090202 A KR1020050090202 A KR 1020050090202A KR 20050090202 A KR20050090202 A KR 20050090202A KR 20070095494 A KR20070095494 A KR 20070095494A
Authority
KR
South Korea
Prior art keywords
adipose tissue
semi
solution
solid gel
gel composition
Prior art date
Application number
KR1020050090202A
Other languages
Korean (ko)
Inventor
손현미
장재덕
장정호
Original Assignee
세원셀론텍(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세원셀론텍(주) filed Critical 세원셀론텍(주)
Priority to KR1020050090202A priority Critical patent/KR20070095494A/en
Priority to PCT/KR2005/003560 priority patent/WO2007037572A1/en
Publication of KR20070095494A publication Critical patent/KR20070095494A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/34Materials or treatment for tissue regeneration for soft tissue reconstruction

Abstract

A semi-solid gel composition for adipose tissue regeneration is provided to obtain a composition for adipose tissue regeneration by mixing collagen in a semi-solid gel state, washed adipose tissue and other several materials. To form a semi-solid gel composition for adipose tissue regeneration, an adipose tissue that is obtained from a human body or an animal and washed and 0.01-5% of gel type collagen are mixed in a volume ratio of 1:8 to 8:1, and an adipose generation facilitating solution, a serum containing growth factor, and an additive containing culture medium are mixed in the aforesaid mixture in a volume ratio of 1:10 to 10:1 (v/v). The washed adipose tissue is obtained by washing the adipose tissue at least three times by adding a 1X~10XPBS(Phosphate-Buffered Saline) solution to which 0.01~1% BSA(Bovine Serum Albumin) is added.

Description

지방 조직 수복용 반고형성 젤 조성물{Semi-Solid Gel Composition For Adipose Tissue Regeneration}Semi-Solid Gel Composition For Adipose Tissue Regeneration

도 1은 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물을 누드 마우스에 주입한 결과를 나타낸 사진,1 is a photograph showing the result of injecting a semi-solid gel composition for adipose tissue repair according to the present invention in nude mice,

도 2는 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물을 이용하여 각 군마다 비교한 부피 추세선을 나타낸 그래프,Figure 2 is a graph showing a volume trend line compared for each group using a semi-solid gel composition for adipose tissue repair according to the present invention,

도 3은 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물의 주입물 크기에 대한 결과를 나타낸 사진,Figure 3 is a photograph showing the results of the injection size of the semi-solid gel composition for adipose tissue repair according to the present invention,

도 4는 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물의 대조군 및 실험군 1, 2에 해당하는 조직염색 결과를 나타낸 사진.Figure 4 is a photograph showing the tissue staining results corresponding to the control group and experimental groups 1 and 2 of the semi-solid gel composition for adipose tissue repair according to the present invention.

본 발명은 지방 조직 수복용 반고형성 젤 조성물에 관한 것으로, 더욱 상세하게는 지방 조직 수세용 용액에 수세된 지방 조직에 콜라겐(Collagen), 지방생성 촉진용액, 혈청(Serum), 그리고, 배지(Medium)와 함께 혼합된 지방 조직 수복용 반고형성 젤 조성물에 관한 것이다.The present invention relates to a semi-solid gel composition for repairing adipose tissue, and more particularly, collagen, adipogenesis-promoting solution, serum, and medium in adipose tissue washed with adipose tissue washing solution. ) Is a semi-solid gel composition for adipose tissue repair.

일반적으로 콜라겐은 섬유아세포, 연골세포, 골아세포, 평활근 세포 등에서 합성되어 분비되며 신체의 모든 단백질 중량의 25% 정도를 구성하고 있다. 콜라겐의 주요 기능은 구조단백질, 골격단백질로서 신체의 장기구조를 형성하는 것이다. 또한 신장 사구체의 기저막에서는 소변을 한외여과하는 역할을 하는데, 이는 크기가 작은 분자는 통과하지만, 단백질과 같은 고분자량의 분자는 통과하지 않는 분자체(sieve)의 역할을 하는 것이다. 그 외 다른 세포외 매트릭스 성분과 특이적인 상호작용을 통하여 세포의 증식과 분화 등에 관여한다는 것도 밝혀졌다.In general, collagen is synthesized and secreted from fibroblasts, chondrocytes, osteoblasts, smooth muscle cells, etc., and constitutes about 25% of the weight of all proteins in the body. The main function of collagen is structural proteins, skeletal proteins to form the organ structure of the body. In addition, the basement membrane of the renal glomerulus is ultrafiltration of urine, which acts as a sieve that passes small molecules but does not pass high molecular weight molecules such as proteins. It has also been found to be involved in the proliferation and differentiation of cells through specific interactions with other extracellular matrix components.

콜라겐은 조직의 구조를 유지해 주는 역할을 하지만, 항상 일정한 형태를 유지하는 것이 아니라 콜라게나아제(collagenase)라 불리는 효소에 의해 연속적으로 분해되고 재구성되며, 보통의 단백질 분해효소(프로테아제, protease)에 의해서는 분해되지 않는다. 한편, 뼈와 같은 조직에서는 그 대사 속도가 매우 느려 콜라겐이 새로운 콜라겐으로 치환되는 데에는 10년 정도 걸린다.Collagen plays a role in maintaining tissue structure, but it does not always maintain a constant shape but is continuously degraded and reconstituted by an enzyme called collagenase, and it is usually by a protease. Does not decompose. On the other hand, in tissues such as bone, the metabolism is so slow that it takes about 10 years for collagen to be replaced with new collagen.

현재 콜라겐은 15종류 이상으로 알려져 있고, 발견된 순서에 따라 번호를 정했다. I형 콜라겐이 최초로 발견되었으며 양적으로도 가장 많다. I형 이외의 콜라겐도 부분적으로 글리신-X-Y의 반복적인 구조를 갖고 있으며 3중 나선 구조로 되어 있다. I형 콜라겐 다음으로 많이 연구된 것이 II, III, IV 형의 콜라겐이다. II형은 연골에, III형은 결합조직에 많이 존재한다. IV형은 섬유상이 아닌 판(sheet)상 편목구조를 형성하며, 기저막에서 발견되는 유일한 콜라겐 성분이다.Currently, there are more than 15 types of collagen, and they are numbered according to the order in which they were found. Type I collagen was first discovered and is the largest in quantity. Collagen other than type I has a repeating structure of glycine-X-Y in part and has a triple helix structure. The next most studied type I collagen is type II, III and IV collagen. Type II is found in cartilage and type III is present in connective tissue. Type IV forms a sheet-like knit structure that is not fibrous and is the only collagen component found in the basement membrane.

결합조직으로부터 콜라겐을 분리하는 방법은 동물의 피부를 작게 떼어 희석 초산에 담가 둔 채로 냉장고에 2, 3일 가량 넣어 두면, 점도 있는 콜라겐 용액이 얻어지는데 이 콜라겐 용액을 중성으로 실온에 방치하면 콜라겐이 겔화된다. [참조 ; Ming-Thau Sheu, Ju-Chun Huang, Geng-Chang yeh, Hsiu-O Ho, Characterization of collagen matrices for cell culture, Biomaterials 22, 1713-1719, 2001] [참조 ; Nimni ME, Cheung DT, Steates B, Kodama M, Sheikkh. Collagen, vol . 3, pp1-37, Eds., Nimni ME, ; biotechnology. Boca Raton, CRC Press, 1988] I형 콜라겐의 경우에는 비교적 용이하게 다량이 단리되며, 졸-겔 전위의 조절이 가능하고, 세포 기능 발현에 좋은 환경을 제공하므로 조직공학 분야의 세포 지지체로서 많이 이용된다.The method of separating collagen from connective tissue is to take small amounts of animal skin and soak it in dilute acetic acid for 2 or 3 days in a refrigerator to obtain a viscous collagen solution. Gelling. [Reference ; Ming-Thau Sheu, Ju-Chun Huang, Geng-Chang yeh, Hsiu-O Ho, Characterization of collagen matrices for cell culture, Biomaterials 22, 1713-1719, 2001; Nimni ME, Cheung DT, Steates B, Kodama M, Sheikkh. Collagen, vol. 3, pp 1-37, Eds., Nimni ME ,; biotechnology. Boca Raton, CRC Press, 1988] In the case of type I collagen, it is relatively easy to isolate a large amount, control the sol-gel potential, and provide a good environment for cell function expression, so it is widely used as a cell support in tissue engineering. do.

또한, 현재 진피 대용품으로 사체 이식(cadaver allograft)을 이용한 진피(Alloderm)가 개발되어 임상에 응용되고 있으며, 소의 콜라겐과 콘드로이틴 황산(chondroitin sulfate)의 복합체로서 진피를 대용하는 인테그라(Integra)라는 상품이 화상치료에 사용되고 있다. 또한 인공 골격(scaffold)과 생체에서 채취한 배양세포를 조합한 일종의 복합적인 인공 진피 개발에도 많이 연구가 시도되고 있다. 이 외에도 콜라겐 스폰지(sponge)의 변형들이 많이 개발되어 있으며 여러 매트릭스 단백질(matrix protein)이나 히아루론산(hyaluronic acid) 등을 이용하여 골격의 기공 크기(pore size)를 조절함으로써 섬유모세포의 생착과 증식을 극대화시킨 연구 결과들이 보고된 바 있다. 최근에는 인체 신생아의 섬유모세포를 polyglactin acid Vicryl mesh에서 배양시켜 상품화된 더마그래프트(Dermagraft)가 시판되어 임상에 응용되고 있다.In addition, the dermis (Alloderm) using a cadaver allograft as a substitute for the dermis has been developed and applied in clinical practice, and a product called Integra, which substitutes the dermis as a complex of bovine collagen and chondroitin sulfate, has been developed. It is used for burn treatment. In addition, a lot of research has been attempted to develop a kind of complex artificial dermis combining a scaffold and cultured cells obtained from living bodies. In addition, many strains of collagen sponge have been developed, and maximizing engraftment and proliferation of fibroblasts by controlling the pore size of the skeleton using various matrix proteins or hyaluronic acid. Investigations have been reported. Recently, commercialized dermagrafts have been commercialized by culturing human neonatal fibroblasts in a polyglactin acid Vicryl mesh.

지방 조직과 관련하여서는 연부조직 재건에 사용되는 대체물질로 콜라겐이 사용되기도 하는데, 예를 들어 이들 물질은 크게 무세포성 진피조직이나 세포외기질(Extracellular matrix, Tissue matrix)들을 공정 처리하여 만든 것과 생물학적 안정성을 가진 합성 중합체 등으로 나눌 수 있다. 이들은 주로 지방 조직의 대체물질로 사용되며 적은 양을 사용할 시 유용하게 사용될 수 있지만 이들 역시 기능적 보강 물질이기보다는 결손을 단순히 충전시키는 역할만을 가진다.In relation to adipose tissue, collagen is sometimes used as a substitute for soft tissue reconstruction. For example, these substances are largely made by processing acellular dermal tissue or extracellular matrix (Tissue matrix) and biological stability. It can be divided into a synthetic polymer having a. They are mainly used as a substitute for adipose tissue and may be useful when used in small amounts, but they also serve to simply fill in the deficiency rather than being functional reinforcement.

또한, 콜라겐 골격에 동물에서 채취한 배양세포를 조합한 복합적인 조직의 재건으로 일부 연구가 시도되고 있지만, 임상에 적용되기까지는 많은 시간이 걸릴 것이라고 예상된다. 현재 임상에서 적용되어지고 있는 지방 조직 이식술은 지방 조직만을 단순히 식염수에 수세하여 대체하는 정도의 기본적인 테크닉으로 조직을 재건하고 있는 상황이다. 이러한 지방 조직 이식술도 1년 이내에 40??60% 이상 부피가 감소하는 단점과 조직의 섬유화와 같은 문제점으로 인해 재수술을 해야 하는 번거로움이 있다.In addition, although some studies have been attempted to reconstruct complex tissues that combine cultured cells collected from animals with collagen skeletons, it is expected that it will take a long time to be applied to clinical applications. The adipose tissue transplantation, which is currently applied in clinical practice, is reconstructing the tissue with a basic technique that replaces only adipose tissue with saline solution. Such adipose tissue graft also has the disadvantage that volume is reduced by more than 40 ?? 60% within a year and has to be re-operated due to problems such as fibrosis of the tissue.

본 발명은 상기와 같은 문제점을 해결하기 위한 것으로, 기존의 스폰지 형태의 scaffold와는 달리 반고형성 젤 형태인 콜라겐과 수세한 지방 조직, 기타 지방 조직내의 세포들을 증식시켜줄 수 있는 몇 가지 물질들을 혼합하여 만든 지방 조직 수복용 조성물로서 기존의 지방 조직 이식술에 비해 훨씬 효과적인 지방 조직 수복용 반고형성 젤 조성물을 제공하는데 그 목적이 있다.The present invention is to solve the above problems, unlike the conventional sponge-type scaffold made of a mixture of several substances that can multiply the cells in collagen and washed adipose tissue, other adipose tissue in the form of semi-solid gel It is an object of the present invention to provide a semi-solid gel composition for adipose tissue repair which is much more effective as a composition for adipose tissue repair than conventional adipose tissue transplantation.

상기와 같은 목적을 달성하기 위한 본 발명의 특징은,Features of the present invention for achieving the above object,

인체 또는 동물로부터 얻어져 수세된 지방 조직과, 0.01~5%의 젤 타입의 콜라겐을 1:8~8:1의 부피비(v/v)로 혼합하고, 혼합물에 지방생성 촉진용액과, 성장인자가 포함된 혈청 및 배지가 포함된 첨가물을 혼합물에 대해 1:10~10:1의 부피비(v/v)로 혼합하는 것을 특징으로 한다.Adipose tissue obtained from a human body or an animal and washed with water and 0.01 to 5% gel type collagen are mixed at a volume ratio (v / v) of 1: 8 to 8: 1. It is characterized in that the additive containing the serum and the medium containing the mixture in a volume ratio (v / v) of 1:10 ~ 10: 1.

여기에서, 인체 또는 동물로부터 얻어진 수세된 지방 조직은 지방 조직 무게의 5~15배의 수세 용액인 0.01~1% BSA(Bovine Serum Albumin)이 첨가된 1X~10X PBS(Phosphate-Buffered Saline) 용액을 첨가하여 지방 조직을 적어도 3회 이상 세척한다.Herein, the washed adipose tissue obtained from a human body or an animal is a 1X-10X Phosphate-Buffered Saline (PBS) solution added with 0.01-1% BSA (Bovine Serum Albumin), which is a 5-15 times the weight of adipose tissue. The adipose tissue is washed at least three times by addition.

여기에서 또한, 상기 수세 용액인 0.01~1% BSA이 첨가된 1X~10X PBS 용액은 정제수 900㎖에 KH2PO4 0.144~1.44g, NaCl 9.000~90.00g, Na2HPO4·7H2O 0.795~7.950g을 용해시켜 pH를 7.2~7.8로 맞춘 후 정제수로 최종부피가 1000㎖이 되게 한 다음 여과하고, 여과된 용액에 항생제 젠타마이신(gentamicin)을 최종농도가 100㎍/㎖이 되도록 첨가하여 1X PBS 용액을 제조하고, 400㎖ 1X PBS 용액에 0.05~5g BSA를 용해시켜 1X~10X PBS 용액으로 최종부피가 500㎖이 되게 한 후 여과한다.Here, the 1X-10X PBS solution to which the water washing solution 0.01 ~ 1% BSA was added was 0.144-1.44g of KH 2 PO 4 , NaCl 9.000-90.00g, Na 2 HPO 4 · 7H 2 O 0.795 in 900 ml of purified water. Dissolve ~ 7.950g, adjust the pH to 7.2 ~ 7.8, make final volume 1000ml with purified water, and then filter, add antibiotic gentamicin (gentamicin) to final concentration of 100㎍ / ㎖ Prepare 1X PBS solution, dissolve 0.05-5g BSA in 400ml 1X PBS solution to make 500ml final volume with 1X ~ 10X PBS solution and filter.

여기에서 또, 상기 0.01~5%의 젤 타입의 콜라겐은 돼지 힘줄(Tendon)로부터 효소처리와 염처리를 하여 얻은 0.01~0.5% 콜라겐 100㎖를 여과하고, 여과된 콜라겐을 반고형성 젤 형태로 만들기 위해 1N NaOH로 pH를 6.5~7.5로 중성 처리한 후, 콜라겐을 20~30℃, 1~15시간 정치 상태로 두었다가 5,000~15,000g, 15~60분간 원심 분리(Centrifuge)하여 상층은 제거하고, 저층에 가라앉은 침전물(Pellet)을 취한 다음, 여기에 생리 완충용액(Physiological Phosphate-Buffer) 10㎖를 첨가하여 제조한 후 사용 전까지 4℃상태로 유지한다.Here, the 0.01 ~ 5% gel type of collagen is filtered from 100 ml of 0.01 ~ 0.5% collagen obtained by the enzyme treatment and salt treatment from pig tendon (Tendon) to make the filtered collagen into a semi-solid gel form In order to neutralize the pH with 6.5-7.5 with 1N NaOH, the collagen was left at 20-30 ° C. for 1-15 hours, and then centrifuged at 5,000-15,000 g for 15-60 minutes to remove the upper layer. After taking down the precipitate (Pellet) in the bottom layer, it is prepared by adding 10ml of Physiological Phosphate-Buffer to it and maintained at 4 ° C until use.

여기에서 또, 상기 지방생성 촉진용액은 정제 대두유(Soybean oil) 20~200g, 글리세롤(glycerol) 10~25g, 난황 인지질(Egg phosphatides) 5~12g, 오레인산소다(Sodium oleate) 0.03~0.3g을 증류수 100㎖에 용해시켜 여과한다.Here, the fat production promoting solution is 20 to 200 g of refined soybean oil (Soybean oil), 10 to 25 g of glycerol (glycerol), 5 to 12 g of egg phosphate (Egg phosphatides), 0.03 to 0.3 g of sodium oleate (Sodium oleate) It is dissolved in 100 ml of distilled water and filtered.

여기에서 또, 상기 배지는 정제수 800㎖에 DMEM(Dulbecco`s Minimum Essential Medium) 파우더 8~11g, NaHNO3(Sodium Bicarbonate) 2000~2400㎎, HEPES(N-2-Hydroxyethylpiperazine-N`-2-Ethane Sulfonic Acid) 2200~2400㎎을 용해시킨 후, 용해시킨 용액의 pH를 6.8~7.8로 맞추고, 정제수로 최종부피가 1000㎖가 되도록 준비하고, 정제수 800㎖에 F-12 파우더 8~11g, NaHNO3 1000~1200㎎을 용해시킨 후, 용해시킨 용액의 pH를 6.8~7.8로 맞추고, 정제수로 최종부피가 1000㎖가 되도록 준비하며, 상기에서 각각 준비된 용액을 부피비 1:1(v/v)로 혼합하여 여과한다.Here, the medium is 8 ~ 11g DMEM (Dulbecco`s Minimum Essential Medium) powder, NaHNO 3 (Sodium Bicarbonate) 2000 ~ 2400 mg, HEPES (N-2-Hydroxyethylpiperazine-N`-2-Ethane in 800 ml of purified water Sulfonic Acid) After dissolving 2200 ~ 2400mg, adjust the pH of the dissolved solution to 6.8 ~ 7.8, prepare final volume to 1000ml with purified water, 8 ~ 11g F-12 powder to 800ml of purified water, NaHNO 3 After dissolving 1000-1200 mg, the pH of the dissolved solution was adjusted to 6.8-7.8, and the final volume was prepared to be 1000 ml with purified water, and the solutions prepared above were mixed at a volume ratio of 1: 1 (v / v). And filter.

여기에서 또, 상기 첨가물은 지방생성 촉진용액과, 성장인자가 포함된 혈청 및 배지를 1:1:1의 부피비(v/v)로 첨가한다.Here, the additive is added to the fat production promoting solution, the growth factor-containing serum and medium in a volume ratio of 1: 1: 1 (v / v).

이하, 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물의 구성을 첨부된 도면을 참조하여 상세하게 설명하면 다음과 같다.Hereinafter, the configuration of the semi-solid gel composition for adipose tissue repair according to the present invention will be described in detail with reference to the accompanying drawings.

하기에서 본 발명을 설명함에 있어, 관련된 공지 기능 또는 구성에 대한 구 체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명은 생략할 것이다. 그리고 후술되는 용어들은 본 발명에서의 기능을 고려하여 정의된 용어들로서 이는 사용자, 운용자의 의도 또는 관례 등에 따라 달라질 수 있다. 그러므로 그 정의는 본 명세서 전반에 걸친 내용을 토대로 내려져야 할 것이다.In the following description of the present invention, if it is determined that specific descriptions of related known functions or configurations may unnecessarily obscure the subject matter of the present invention, the detailed description thereof will be omitted. Terms to be described later are terms defined in consideration of functions in the present invention, and may be changed according to intentions or customs of users or operators. Therefore, the definition should be made based on the contents throughout the specification.

도 1은 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물을 누드 마우스에 주입한 결과를 나타낸 사진이며, 도 2는 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물을 이용하여 각 군마다 비교한 부피 추세선을 나타낸 그래프이고, 도 3은 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물의 주입물 크기에 대한 결과를 나타낸 사진이고, 도 4는 본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물의 대조군 및 실험군 1, 2에 해당하는 조직염색 결과를 나타낸 사진이다.Figure 1 is a photograph showing the result of injecting a semi-solid gel composition for adipose tissue repair according to the present invention in nude mice, Figure 2 is compared with each group using a semi-solid gel composition for adipose tissue repair according to the present invention Figure 3 is a graph showing the volume trend line, Figure 3 is a photograph showing the results of the injection size of the semi-solid gel composition for adipose tissue repair according to the present invention, Figure 4 is a semi-solid gel composition for adipose tissue repair according to the present invention It is a photograph showing the tissue staining results corresponding to the control group and the experimental groups 1 and 2.

본 발명에 따른 지방 조직 수복용 반고형성 젤 조성물은 인체 또는 동물로부터 얻어져 수세된 지방 조직과, 0.01~5%의 젤 타입의 콜라겐을 1:8~8:1의 부피비(v/v)로 혼합하고, 혼합물에 지방생성 촉진용액과, 성장인자가 포함된 혈청 및 배지가 포함된 첨가물을 혼합물에 대해 1:10~10:1의 부피비(v/v)로 혼합하여 완성한다. 여기에서, 첨가물은 지방생성 촉진용액과, 성장인자가 포함된 혈청 및 배지를 1:1:1 의 부피비(v/v)로 첨가한다. The semi-solid gel composition for adipose tissue repair according to the present invention is obtained by washing with adipose tissue obtained from a human body or an animal and washing the adipose tissue with 0.01 to 5% of the gel type collagen in a volume ratio (v / v) of 1: 8 to 8: 1. The mixture is mixed with the adipogenic solution, the serum containing growth factors, and the medium containing the additives in a volume ratio (v / v) of 1:10 to 10: 1 with respect to the mixture. Here, the additive is added to the fat production promoting solution, the growth factor-containing serum and medium in a volume ratio of 1: 1: 1 (v / v).

이때, 인체 또는 동물로부터 얻어진 수세된 지방 조직은 지방 조직 무게의 5~15배의 수세 용액인 0.01~1% BSA(Bovine Serum Albumin)이 첨가된 1X~10X PBS(Phosphate-Buffered Saline) 용액을 첨가하여 지방 조직을 적어도 3회 이상 세 척한다. 여기에서, 수세 용액인 0.01~1% BSA(Bovine Serum Albumin)이 첨가된 1X~10X PBS(Phosphate-Buffered Saline) 용액은 정제수 900㎖에 KH2PO4 0.144~1.44g, NaCl 9.000~90.00g, Na2HPO4·7H2O 0.795~7.950g을 용해시켜 pH를 7.2~7.8로 맞춘 후 정제수로 최종부피가 1000㎖이 되게 한 다음 여과하고, 여과된 용액에 항생제 젠타마이신(gentamicin)을 최종농도가 100㎍/㎖이 되도록 첨가하여 1X PBS 용액을 제조하고, 400㎖ 1X PBS 용액에 0.05~5g BSA를 용해시켜 1X~10X PBS 용액으로 최종부피가 500㎖이 되게 한 후 여과한다.At this time, the washed adipose tissue obtained from the human body or animal is added to the 1X ~ 10X Phosphate-Buffered Saline (PBS) solution with 0.01-1% BSA (Bovine Serum Albumin), which is a 5-15 times the weight of the adipose tissue weight. Clean the adipose tissue at least three times. Here, 1X ~ 10X PBS (Phosphate-Buffered Saline) solution to which 0.01-1% BSA (Bovine Serum Albumin) was added to the washed water, 0.144 ~ 1.44g of KH 2 PO 4 , 9.000-90.00g, Dissolve 0.795 ~ 7.950g of Na 2 HPO 4 · 7H 2 O to adjust the pH to 7.2 ~ 7.8, make the final volume 1000ml with purified water, and then filter, and the final concentration of antibiotic gentamicin (gentamicin) in the filtered solution. Is added to 100 ㎍ / ㎖ to prepare a 1X PBS solution, dissolved 0.05 ~ 5g BSA in 400ml 1X PBS solution to make a final volume of 500ml with 1X ~ 10X PBS solution and filtered.

또한, 0.01~5%의 젤 타입의 콜라겐은 돼지 힘줄(Tendon)로부터 효소처리와 염처리를 하여 얻은 0.01~0.5% 콜라겐 100㎖를 여과하고, 여과된 콜라겐을 반고형성 젤 형태로 만들기 위해 1N NaOH로 pH를 6.5~7.5로 중성 처리한 후, 콜라겐을 20~30℃, 1~15시간 정치 상태로 두었다가 5,000~15,000g, 15~60분간 원심분리(Centrifuge)하여 상층은 제거하고, 저층에 가라앉은 침전물(Pellet)을 취한 다음, 여기에 생리 완충용액(Physiological Phosphate-Buffer) 10㎖를 첨가하여 제조한 후 사용 전까지 4℃상태로 유지한다.In addition, 0.01 ~ 5% gel type collagen was filtered from 100 ml of 0.01 ~ 0.5% collagen obtained by enzyme treatment and salt treatment from pig tendon (Tendon), 1N NaOH to make the filtered collagen into semi-solid gel form Neutralize the pH to 6.5 ~ 7.5 and leave the collagen at 20 ~ 30 ℃ for 1 ~ 15 hours, then centrifuge at 5,000 ~ 15,000g for 15 ~ 60 minutes to remove the upper layer and go to the lower layer. After taking the precipitate (Pellet), it is prepared by adding 10ml of Physiological Phosphate-Buffer to it and maintained at 4 ℃ until use.

또, 지방생성 촉진용액은 정제 대두유(Soybean oil) 20~200g, 글리세롤(glycerol) 10~25g, 난황 인지질(Egg phosphatides) 5~12g, 오레인산소다(Sodium oleate) 0.03~0.3g을 증류수 100㎖에 용해시켜 여과한다.In addition, the fat production promoting solution is 20 ~ 200g of refined soybean oil, 10-25g of glycerol, 5-12g of egg phosphatides, 0.03 ~ 0.3g of sodium oleate, 100ml of distilled water Dissolved in and filtered.

한편, 배지는 정제수 800㎖에 DMEM 파우더 8~11g, NaHNO3(Sodium Bicarbonate) 2000~2400㎎, HEPES(N-2-Hydroxyethylpiperazine-N`-2-Ethane Sulfonic Acid) 2200~2400㎎을 용해시킨 후, 용해시킨 용액의 pH를 6.8~7.8로 맞추고, 정제수로 최종부피가 1000㎖가 되도록 준비하고, 정제수 800㎖에 F-12 파우더 8~11g, NaHNO3 1000~1200㎎을 용해시킨 후, 용해시킨 용액의 pH를 6.8~7.8로 맞추고, 정제수로 최종부피가 1000㎖가 되도록 준비하며, 상기에서 각각 준비된 용액을 부피비 1:1(v/v)로 혼합하여 여과한다.On the other hand, the medium was dissolved in DMEM powder 8-11g, NaHNO 3 (Sodium Bicarbonate) 2000 ~ 2400mg, HEPES (N-2-Hydroxyethylpiperazine-N`-2-Ethane Sulfonic Acid) 2200 ~ 2400mg in 800ml of purified water. The pH of the dissolved solution was adjusted to 6.8-7.8, and the final volume was prepared to be 1000 ml with purified water. After dissolving 8-11 g of F-12 powder and 1000-1200 mg of NaHNO3 in 800 ml of purified water, the dissolved solution was dissolved. The pH of the solution was adjusted to 6.8-7.8, and the final volume was prepared to be 1000 ml with purified water, and the solutions prepared above were mixed and mixed at a volume ratio of 1: 1 (v / v).

이하, 본 발명의 실시 예들을 통하여 본 발명을 더욱 상세하게 설명하기로 한다. 이들 실시 예들은 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시 예들에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to the following examples. These examples are only intended to illustrate the invention, so the scope of the invention is not to be construed as limited by these embodiments.

《실시예 1-Liposuction한 지방 조직을 이용한 지방 조직 수복용 젤 조성의 예》Example 1-Example of Composition of Gel for Adipose Tissue Repair Using Liposuction of Adipose Tissue

사람으로부터 당일에 지방흡입(liposuction)한 지방 조직을 이용한 지방 조직 수복용 젤 조성물을 제조하는 과정은 다음과 같다.The procedure for preparing a gel composition for adipose tissue repair using adipose tissue (liposuction) on a day from a person is as follows.

먼저, -20~4℃ 냉장 상태로 이동되어져 온 지방흡입(liposuction)한 지방 조직을 칭량하기 위해 50㎖ 원심 분리 튜브(centrifuge tube)의 조직이 담겨져 있지 않은 용기의 무게를 측정하고, 조직이 담겨 있는 상태에서 용기의 전체 무게를 측정하여 그 뺀 값을 조직의 무게로 한다.First, in order to weigh the liposuctioned adipose tissue that has been moved to the refrigerated state at -20 to 4 ° C, the weight of the container containing no tissue of the 50 ml centrifuge tube is measured, and the tissue is contained. The total weight of the container is measured while the weight of the container is subtracted.

조직의 무게를 칭량한 후 지방 조직 수세용액을 조직무게의 5~15배로 첨가한 후 50㎖ 원심 분리기 튜브 뚜껑을 닫고 부드럽게 흔들어 조직을 씻어준다. 수세 과정은 총 3번 반복한다.After weighing the tissue, add the adipose tissue washing solution 5 to 15 times the tissue weight, and close the 50 ml centrifuge tube cap and shake gently to wash the tissue. The washing process is repeated three times in total.

이렇게 준비된 지방 조직을 한쪽 주사기에 담고, 다른 쪽 주사기에는 0.01~5% 젤 타입의 콜라겐을 담아 1:8~8:1(v/v)로 혼합하되, 주사기 커넥터(connector)를 이용하여 골고루 혼합되도록 한다.The prepared adipose tissue is put in one syringe, and the other syringe is mixed with 0.01 ~ 5% gel-type collagen at 1: 8-8: 1 (v / v), but mixed evenly using a syringe connector. Be sure to

이때, 지방 조직내의 세포증식을 유도하는 물질인 지방생성 촉진용액, 혈청, 배지를 1:1:1(v/v/v)의 부피비로 같이 혼합하고, 지방 조직과 콜라겐이 혼합된 혼합물에 대해 이를 1:10~10:1의 부피비(v/v)로 혼합하여 젤 조성물을 만든다.At this time, the adipogenic solution, serum, and medium, which is a substance that induces cell proliferation in adipose tissue, are mixed together in a volume ratio of 1: 1: 1 (v / v / v), and the mixture of adipose tissue and collagen is mixed. It is mixed in a volume ratio (v / v) of 1:10 to 10: 1 to make a gel composition.

지방 조직 수복용 젤 조성물을 각 실험군에 주입한 결과는 도 1에 나타내었다.The result of injecting the adipose tissue repair gel composition into each experimental group is shown in FIG. 1.

《실시예 2-조직수복용 젤 조성물을 이용한 누드 마우스 실험의 예》Example 2 Example of Nude Mouse Experiment Using Gel Composition for Tissue Repair

지방흡입(liposuction)한 지방 조직을 이용한 지방 조직 수복용 젤 조성물을 만든 후 현재 임상에서 사용하고 있는 방법인 식염수로만 수세한 지방 조직만 그대로 사용한 것을 대조군(Control)으로 하고 실험군 1로 지방 조직 수세용액으로 수세한 지방 조직과 콜라겐을 8:1(v/v), 실험군 2로 지방 조직 수세용액으로 수세한 지방 조직과 콜라겐을 1:8(v/v)로 나누어 실험을 진행하였다.After making a gel composition for adipose tissue restoration using liposuction adipose tissue, only the adipose tissue washed with saline, which is a method currently used in clinical use, was used as a control, and the adipose tissue washing solution in Experiment 1 The experiment was performed by dividing the adipose tissue and collagen washed with 8: 1 (v / v) and the experimental group 2 with the adipose tissue and collagen washed with adipose tissue washing solution 1: 8 (v / v).

이 실험을 진행하기 위해 BALB c/Nu 8주령, 암컷을 각 군마다 5마리씩 사용하였으며, 각 대조군과 실험군1, 2마다 누드 마우스의 견갑골에 총 부피가 1㎖가 되도록 주사하여 1, 2, 3.5, 7, 11주마다 주입물 크기(mass size)를 재고, 샘플링 데이(sampling day)마다 누드 마우스를 희생하여 샘플을 취하였다.To carry out this experiment, 5 females of BALB c / Nu 8 weeks old and 5 females were used in each group, and the scapula of nude mice in each control group and experimental group 1 and 2 were injected with a total volume of 1 ml to 1, 2, 3.5 Samples were taken at the expense of mass size every 7, week and 11 weeks, and at the expense of nude mice every sampling day.

그리고, 각 군의 샘플 주입물 크기를 이용하여 평균 부피를 계산하여 부피의 추세선을 그래프로 나타내어 지방 조직 수복용 젤 조성물의 부피가 현재 임상에서 사용되어지고 있는 방법에 비해 얼마만큼의 효과가 있는지를 계산하였으며, 지방 조직의 증식과 발현을 보기 위해 조직염색인 Oil-red O 염색을 실시하여 그 결과를 해석하였다.In addition, the average volume is calculated using the sample injection size of each group, and a graph of the volume trend graph shows how much the volume of the adipose tissue repair gel composition is effective compared to the method currently used in the clinic. In order to see the proliferation and expression of adipose tissue, tissue staining, Oil-red O staining, was performed to interpret the results.

아래의 표 1은 각 군의 조성물을 표시한 것이다.Table 1 below shows the composition of each group.

[표 1] 대조군과 실험군의 지방 조직 수복용 반고형성 젤 조성물Table 1 Semi-solid Gel Composition for Adipose Tissue Repair in Control and Experimental Groups

지방조직Adipose tissue 지방생성 촉진용액Fat Producing Solution 혈청serum 배지badge 대조군Control 식염수 수세 지방조직Saline flushing adipose tissue XX XX XX 실험군 1Experimental group 1 지방조직 수세용액으로 수세한 지방조직Adipose tissue washed with adipose tissue washing solution 실험군 2Experiment group 2 지방조직 수세용액으로 수세한 지방조직Adipose tissue washed with adipose tissue washing solution

지방조직 수복용 젤 조성물을 이용하여 각 군마다 비교한 부피 추세선을 도 2에 나타내었으며, 지방조직 수복용 젤 조성물의 주입물 크기(mass size)에 대한 결과는 도 3에, 지방조직 수복용 젤 조성물의 대조군 및 실험군 1, 2에 해당하는 조직염색 결과는 도 4에 나타내었다.       The volume trendline compared to each group using the adipose tissue repair gel composition is shown in FIG. 2, and the results of the mass size of the adipose tissue repair gel composition are shown in FIG. 3. The tissue staining results corresponding to the control group and the experimental groups 1 and 2 of the composition are shown in FIG. 4.

따라서, 현재의 지방 조직 이식술은 지방 조직을 덩어리째 하여 식염수로 수세한 후 결손 부위를 채워줌으로 인해 지방 조직의 량이 많을 경우 이식조직의 궤사와 합병증들, 수술 후 부피가 줄어들어 수차례 다시 시술해야 하는 문제점, 이식 후에 발생하는 조직의 섬유화, 물리적 손상에 의한 세포괴사 등과 같은 여러 가지 문제점을 안고 있는 것이 사실이다.      Therefore, current adipose tissue grafts are filled with adipose tissue, washed with saline, and filled with defects. It is true that there are various problems such as fibrosis, tissue necrosis caused by physical damage, and the like.

더욱이 부피가 줄어들어 수차례 다시 시술해야 하는 문제점은 환자의 입장에서 굉장히 많은 경제적, 신체적인 부담감을 준다.Moreover, the problem of having to reduce the volume and repeat the procedure several times puts a lot of economic and physical burden on the part of the patient.

이에 본 발명은 지방 조직 수세용액을 사용하여 지방 조직을 수세함으로 인 해 지방 조직내의 지방세포들을 최대한 활성화 상태로 만들어 주고, 여기에 반고형성 젤 형태의 콜라겐을 사용하여 생착과 세포의 증식을 증대시킬 뿐만 아니라, 주입형 형태(Injectable type)로 시술면에서도 굉장히 간편함을 그 특징으로 한다. Therefore, the present invention makes the fat cells in the adipose tissue as active as possible by washing the adipose tissue using the adipose tissue washing solution, and using the semi-solid gel form collagen to increase the engraftment and the proliferation of the cells. In addition, the injectable type (Injectable type) is characterized by a very simple in terms of treatment.

또한, 지방 조직 내의 활성화된 세포들의 성장인자를 공급함으로 혈관을 생성하도록 하여 결국에는 원래의 지방 조직과 함께 유합되도록 함으로 인해 새로운 지방 조직 이식이 가능하다.In addition, new adipose tissue transplantation is possible by supplying growth factors of activated cells in adipose tissue to generate blood vessels and eventually coalescing with the original adipose tissue.

상기와 같이 구성되는 본 발명인 지방 조직 수복용 반고형성 젤 조성물에 따르면, 기존의 스폰지 형태의 scaffold와는 달리 반고형성 젤 형태인 콜라겐과 수세한 지방 조직, 기타 지방 조직내의 세포들을 증식시켜줄 수 있는 몇 가지 물질들을 혼합하여 만든 지방 조직 수복용 조성물로서 기존의 지방 조직 이식술에 비해 훨씬 효과적일 수 있다.According to the present invention, the semi-solid gel composition for adipose tissue repair, which is configured as described above, unlike the conventional sponge-type scaffold, some of the cells that can proliferate the cells in the collagen, the washed adipose tissue, and other adipose tissue in the form of a semi-solid gel It is a composition for repairing adipose tissue made of a mixture of substances, which may be much more effective than conventional adipose tissue transplantation.

본 발명은 다양하게 변형될 수 있고 여러 가지 형태를 취할 수 있으며 상기 발명의 상세한 설명에서는 그에 따른 특별한 실시 예에 대해서만 기술하였다. 하지만 본 발명은 상세한 설명에서 언급되는 ]특별한 형태로 한정되는 것이 아닌 것으로 이해되어야 하며, 오히려 첨부된 청구범위에 의해 정의되는 본 발명의 정신과 범위 내에 있는 모든 변형물과 균등물 및 대체물을 포함하는 것으로 이해되어야 한다.As those skilled in the art would realize, the described embodiments may be modified in various ways, all without departing from the spirit or scope of the present invention. It is to be understood, however, that the invention is not to be limited to the specific forms mentioned in the description, but rather includes all modifications, equivalents, and substitutions within the spirit and scope of the invention as defined by the appended claims. It must be understood.

Claims (7)

인체 또는 동물로부터 얻어져 수세된 지방 조직과, 0.01~5%의 젤 타입의 콜라겐을 1:8~8:1의 부피비(v/v)로 혼합하고, 혼합물에 지방생성 촉진용액과, 성장인자가 포함된 혈청 및 배지가 포함된 첨가물을 혼합물에 대해 1:10~10:1의 부피비(v/v)로 혼합하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.Adipose tissue obtained from a human body or an animal and washed with water and 0.01 to 5% gel type collagen are mixed at a volume ratio (v / v) of 1: 8 to 8: 1. Semi-solid gel composition for adipose tissue repair, characterized in that the mixture containing the serum and the medium containing the additives in a volume ratio (v / v) of 1:10 to 10: 1. 제 1 항에 있어서,The method of claim 1, 인체 또는 동물로부터 얻어진 수세된 지방 조직은,Washed adipose tissue obtained from the human body or animals, 지방 조직 무게의 5~15배의 수세 용액인 0.01~1% BSA(Bovine Serum Albumin)이 첨가된 1X~10X PBS(Phosphate-Buffered Saline) 용액을 첨가하여 지방 조직을 적어도 3회 이상 세척하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.Washing adipose tissue at least three times by adding 1X ~ 10X Phosphate-Buffered Saline (PBS) solution to which 0.01-1% BSA (Bovine Serum Albumin) was added, which is 5-15 times the weight of adipose tissue. Semi-solid gel composition for fat tissue repair. 제 2 항에 있어서,The method of claim 2, 상기 수세 용액인 0.01~1% BSA이 첨가된 1X~10X PBS 용액은,The 1X-10X PBS solution to which 0.01-1% BSA which is the said water washing solution is added, 정제수 900㎖에 KH2PO4 0.144~1.44g, NaCl 9.000~90.00g, Na2HPO4·7H2O 0.795~7.950g을 용해시켜 pH를 7.2~7.8로 맞춘 후 정제수로 최종부피가 1000㎖이 되게 한 다음 여과하고, 여과된 용액에 항생제 젠타마이신(gentamicin)을 최종농도 가 100㎍/㎖이 되도록 첨가하여 1X PBS 용액을 제조하고, 400㎖ 1X PBS 용액에 0.05~5g BSA를 용해시켜 1X~10X PBS 용액으로 최종부피가 500㎖이 되게 한 후 여과하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.After dissolving 0.144 ~ 1.44g of KH 2 PO 4 , 9.000 ~ 90.00g of NaCl, 0.795 ~ 7.950g of Na 2 HPO 4 · 7H 2 O in 900ml of purified water, adjust the pH to 7.2 ~ 8.8 After filtering, and adding the antibiotic gentamicin (gentamicin) to the final concentration of 100 ㎍ / ㎖ to prepare a 1X PBS solution, dissolved 0.05 ~ 5g BSA in 400ml 1X PBS solution to 1X ~ Semi-solid gel composition for adipose tissue repair, characterized in that the final volume to 500ml with 10X PBS solution and then filtered. 제 1 항에 있어서,The method of claim 1, 상기 0.01~5%의 젤 타입의 콜라겐은,The collagen of the gel type of the said 0.01-5%, 돼지 힘줄(Tendon)로부터 효소처리와 염처리를 하여 얻은 0.01~0.5% 콜라겐 100㎖를 여과하고, 여과된 콜라겐을 반고형성 젤 형태로 만들기 위해 1N NaOH로 pH를 6.5~7.5로 중성 처리한 후, 콜라겐을 20~30℃, 1~15시간 정치 상태로 두었다가 5,000~15,000g, 15~60분간 원심분리(Centrifuge)하여 상층은 제거하고, 저층에 가라앉은 침전물(Pellet)를 취한 다음, 여기에 생리 완충용액(Physiological Phosphate-Buffer) 10㎖를 첨가하여 제조한 후 사용 전까지 4℃상태로 유지하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.100 ml of 0.01 ~ 0.5% collagen obtained by enzyme treatment and salt treatment from pig tendon (Tendon) and neutralized with 1N NaOH to 6.5 ~ 7.5 in order to make the filtered collagen into semi-solid gel form, The collagen was left at 20 to 30 ° C for 1 to 15 hours, then centrifuged at 5,000 to 15,000 g for 15 to 60 minutes to remove the upper layer, and the precipitate was settled in the lower layer. Semi-solid gel composition for repairing adipose tissue, which is prepared by adding 10 ml of a buffer solution (Physiological Phosphate-Buffer) and maintaining it at 4 ° C. until use. 제 1 항에 있어서,The method of claim 1, 상기 지방생성 촉진용액은,The fat production promoting solution, 정제 대두유(Soybean oil) 20~200g, 글리세롤(glycerol) 10~25g, 난황 인지질(Egg phosphatides) 5~12g, 오레인산소다(Sodium oleate) 0.03~0.3g을 증류수 100㎖에 용해시켜 여과하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.Purified soybean oil 20 ~ 200g, glycerol 10 ~ 25g, egg yolk phosphatides 5 ~ 12g, sodium oleate 0.03 ~ 0.3g dissolved in 100ml of distilled water and filtered Semi-solid gel composition for fat tissue repair. 제 1 항에 있어서,The method of claim 1, 상기 배지는,The badge, 정제수 800㎖에 DMEM(Dulbecco`s Minimum Essential Medium) 파우더 8~11g, NaHNO3(Sodium Bicarbonate) 2000~2400㎎, HEPES(N-2-Hydroxyethylpiperazine-N`-2-Ethane Sulfonic Acid) 2200~2400㎎을 용해시킨 후, 용해시킨 용액의 pH를 6.8~7.8로 맞추고, 정제수로 최종부피가 1000㎖가 되도록 준비하고,DMEM (Dulbecco`s Minimum Essential Medium) Powder 8 ~ 11g in 800ml of purified water, NaHNO 3 (Sodium Bicarbonate) 2000 ~ 2400mg, HEPES (N-2-Hydroxyethylpiperazine-N`-2-Ethane Sulfonic Acid) 2200 ~ 2400mg After dissolving the solution, adjust the pH of the dissolved solution to 6.8-7.8, prepare the final volume to be 1000ml with purified water, 정제수 800㎖에 F-12 파우더 8~11g, NaHNO3 1000~1200㎎을 용해시킨 후, 용해시킨 용액의 pH를 6.8~7.8로 맞추고, 정제수로 최종부피가 1000㎖가 되도록 준비하며,Dissolve 8-11 g of F-12 powder and 1000-1200 mg of NaHNO 3 in 800 ml of purified water, adjust the pH of the dissolved solution to 6.8-7.8, and prepare the final volume to 1000 ml with purified water. 상기에서 각각 준비된 용액을 부피비 1:1(v/v)로 혼합하여 여과하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.Semi-solid gel composition for adipose tissue repair, characterized in that the solution prepared by mixing each of the volume ratio 1: 1 (v / v) by filtration. 제 1 항에 있어서,The method of claim 1, 상기 첨가물은,The additive is 지방생성 촉진용액과, 성장인자가 포함된 혈청 및 배지를 1:1:1의 부피비(v/v)로 첨가하는 것을 특징으로 하는 지방 조직 수복용 반고형성 젤 조성물.A semi-solid gel composition for repairing adipose tissue, comprising adding an adipogenesis promoting solution, a serum containing growth factor, and a medium in a volume ratio of 1: 1: 1 (v / v).
KR1020050090202A 2005-09-28 2005-09-28 Semi-solid gel composition for adipose tissue regeneration KR20070095494A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020050090202A KR20070095494A (en) 2005-09-28 2005-09-28 Semi-solid gel composition for adipose tissue regeneration
PCT/KR2005/003560 WO2007037572A1 (en) 2005-09-28 2005-10-25 Semi-solid gel composition for adipose tissue regeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050090202A KR20070095494A (en) 2005-09-28 2005-09-28 Semi-solid gel composition for adipose tissue regeneration

Publications (1)

Publication Number Publication Date
KR20070095494A true KR20070095494A (en) 2007-10-01

Family

ID=37899963

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050090202A KR20070095494A (en) 2005-09-28 2005-09-28 Semi-solid gel composition for adipose tissue regeneration

Country Status (2)

Country Link
KR (1) KR20070095494A (en)
WO (1) WO2007037572A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009102452A2 (en) * 2008-02-11 2009-08-20 The Johns Hopkins University Compositions and methods for implantation of adipose tissue and adipose tissue products
CN102575229A (en) * 2009-08-11 2012-07-11 约翰霍普金斯大学 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US20170015973A1 (en) * 2014-03-10 2017-01-19 Medtrain Technologies, Llc Collagen hydrogel kit and methods of making a collagen hydrogel
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
US6475800B1 (en) * 1999-07-22 2002-11-05 Instrumentation Metrics, Inc. Intra-serum and intra-gel for modeling human skin tissue
FR2819265B1 (en) * 2001-01-10 2004-01-02 Centre Nat Rech Scient EXTRAMEDULAR ADIPOSE TISSUE CELLS AND THEIR APPLICATIONS IN THE RECONSTRUCTION OF HEMATOPOIETIC LINES
CA2469370C (en) * 2001-12-07 2014-07-08 Macropore Biosurgery, Inc. Adipose-derived cell processing unit
EP1496978A4 (en) * 2002-04-03 2006-11-29 Artecel Sciences Inc Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof

Also Published As

Publication number Publication date
WO2007037572A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
KR20070095494A (en) Semi-solid gel composition for adipose tissue regeneration
Liu et al. Marine collagen scaffolds in tissue engineering
Cunniffe et al. Porous decellularized tissue engineered hypertrophic cartilage as a scaffold for large bone defect healing
Korpayev et al. Chitosan/collagen based biomimetic osteochondral tissue constructs: A growth factor-free approach
Vavken et al. TRITON‐X is most effective among three decellularization agents for ACL tissue engineering
Zhang et al. Functional neovascularization in tissue engineering with porcine acellular dermal matrix and human umbilical vein endothelial cells
CN108310467A (en) A kind of packaging cell-derived extracellular matrix membrane composite bone repairing material and its preparation method and application
CN106075584B (en) Syringeability cartilage takes off extracellular matrix mixing decalcified bone matrix hydrogel and preparation method thereof
Kim et al. Fabrication of duck’s feet collagen–silk hybrid biomaterial for tissue engineering
Hou et al. Printing 3D vagina tissue analogues with vagina decellularized extracellular matrix bioink
DE10026789B4 (en) Cartilage replacement and process for its manufacture
KR20110138765A (en) Composite filler comprising cells isolated from human adipose tissue and hyaluronic acid derivative
Jiang et al. Decellularized extracellular matrix: a promising strategy for skin repair and regeneration
KR20210005562A (en) Decellularized bone biomaterial reinforced with a hydrogel containing decellularized extracellular bone matrix
Phang et al. Advancements in extracellular matrix-based biomaterials and biofabrication of 3D organotypic skin models
Zhu et al. Three-dimensionally printed porous biomimetic composite for sustained release of recombinant human bone morphogenetic protein 9 to promote osteointegration
Pan et al. Systematic review on the application of 3D-bioprinting technology in orthoregeneration: current achievements and open challenges
Lee et al. Three-dimensional artificial skin construct bioprinted with a marine-based biocomposite
CN1232233C (en) Tissue engineering corium and its preparation method
Ghosh et al. Decellularized extracellular matrix and silk fibroin-based hybrid biomaterials: A comprehensive review on fabrication techniques and tissue-specific applications
Martin et al. Producing prefabricated tissues and organs via tissue engineering
US20080317860A1 (en) Use of a Polysaccharide Which is Excreted by the Vibrio Diabolicus Species For the Engineering of Non-Mineralized Connective Tissue
Han et al. Microribbon-based hydrogels accelerate stem cell-based bone regeneration in a mouse critical-size cranial defect model
Huang et al. Personalized 3D‐Printed Scaffolds with Multiple Bioactivities for Bioroot Regeneration
CN115216441A (en) Composite scaffold for three-dimensional culture of stem cells and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
N231 Notification of change of applicant
N231 Notification of change of applicant
AMND Amendment
E601 Decision to refuse application
J201 Request for trial against refusal decision
AMND Amendment
E801 Decision on dismissal of amendment
B601 Maintenance of original decision after re-examination before a trial
J301 Trial decision

Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070411

Effective date: 20080516

Free format text: TRIAL NUMBER: 2007101003807; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20070411

Effective date: 20080516